As the cost of "sequencing" DNA has dropped, more and more patients are undergoing genetic testing. How will the medical industry use that data to further research and clinical practice while preserving the privacy of patients? David Yizhar, the founder and CEO of Israeli startup Geneyx, thinks blockchain technology could offer a solution.
The device has closed 12 gaps in the known human genome.
Our ancestors shared many genetic traits related to conditions of the immune system and skin, as well as psychological issues.
The long standing support behind large scientific databases may begin to wane, as scientists question if bigger is always better